Annotated Medicine and Device Lists


Darunavir

This medicine is present in:

List Section Observation
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 03.04. ANTIVIRALES No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Retroviral Treatment Programme No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.07 ANTIVIRALS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 05. ANTIVIRALES DE USO SISTÉMICO No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 05.03.03 Protease Inhibitors No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.2.3. Protease inhibitors Age or weight restriction: >3 years
PAHO Strategic Fund Medicine List 2.6.1. Antiretrovirals No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Retroviral Treatment Programme No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 04. Antifungicos y Antivirales Others observations:
Como etanoato. Tabletas recubiertas.
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
FCO X 60 TAB
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.07 ANTIVIRALS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 8:18 Antiretroviral Agents No observations
Haiti. National List of Essential Medicines 06.04.02.03 Protease inhibitors (PIs) No observations

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.6.1. Antiretrovirals No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.07 ANTIVIRALS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.2.3. Protease inhibitors Age or weight restriction: >3 years
PAHO Strategic Fund Medicine List 2.6.1. Antiretrovirals No observations
Haiti. National List of Essential Medicines 06.04.02.03 Protease inhibitors (PIs) No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.2.3. Protease inhibitors Age or weight restriction: >3 years
PAHO Strategic Fund Medicine List 2.6.1. Antiretrovirals No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Haiti. National List of Essential Medicines 06.04.02.03 Protease inhibitors (PIs) No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.2.3. Protease inhibitors Age or weight restriction: >3 years
PAHO Strategic Fund Medicine List 2.6.1. Antiretrovirals No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
Haiti. National List of Essential Medicines 06.04.02.03 Protease inhibitors (PIs) No observations

Information Resources: Darunavir

Loading ...
Loading ...
Loading ...
No information available